Abacus dx Allergy 2024 Showcase

Abacus dx creates value by connecting innovative global suppliers with Australasian customers. We are market leaders in automation for allergy and autoimmunity with the Thermo Fisher range of Phadia™ Laboratory Systems to optimise workflow efficiency for accurate, reproducible test results.

With over 500 whole allergens and over 100 allergen components, clinicians can identify allergic triggers, differentiate between primary sensitisation and cross-reactivity, assess the risk for systemic reactions, and determine allergens for successful immunotherapy.

“Gold standard testing technology you can trust”

Thermo Fisher Scientific ImmunoCAP Allergy tests

Thermo Fisher Scientific ImmunoDiagnostics (previously known as Phadia) is the global leader in allergy and autoimmunity diagnostics, offering instrument systems and reagents to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases commonly recognised as the gold standard.

ImmunoCAP Specific IgE is the worldwide gold standard in in vitro allergy diagnostics designed to aid providers in the diagnosis of allergic diseases including allergic asthma, allergic rhinitis, and food allergies, with more than 550 whole allergens and allergen mixes, and 100 allergen components available.

ImmunoCAP Specific IgE and IgG

As pioneers in allergy diagnostics Thermo Fisher Scientific have more than 50 years of experience in allergen production and specific IgE product development with products documented in more than 6,000 publications and referenced in multiple health guidelines.

ImmunoCAP components

More than 100 allergen components help clinicians differentiate between primary sensitization and cross-reactivity, assess the risk for systemic reactions, and determine allergens for successful immunotherapy.

ImmunoCAP Molecular Allergology

Getting it right the first time with component-resolved diagnostics to control allergic rhinitis and improve asthma outcome. Use ImmunoCAP Total IgE and Specific IgE tests with both Whole Allergens and Allergen Components to improve the diagnosis before management.

EliA autoimmune

Thermo Fisher Scientific EliA portfolio offers one of the broadest portfolios on the market, consisting of clinically relevant markers developed into the highest quality tests to support in the diagnosis of autoimmune diseases, potentially improving patient outcomes.

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC